PTC Therapeutics Quote, Financials, Valuation and Earnings

PTC Therapeutics Price Quote

+0.23 (+0.7%)
(Updated: July 22, 2024 at 12:55 PM ET)

PTC Therapeutics Key Stats

PTC Therapeutics (PTCT) is a Sell

Day range:
$32.41 - $33.62
52-week range:
$17.53 - $42.14
Dividend yield:
P/E ratio:
P/S ratio:
P/B ratio:

Avg. volume:
1-year change:
Market cap:

How Much Does PTC Therapeutics Make?

Is PTC Therapeutics Growing As A Company?

  • What Is PTC Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.05%
  • What Is PTC Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

PTC Therapeutics Stock Price Performance

  • Did PTC Therapeutics Stock Go Up Last Month?
    PTC Therapeutics share price went down by -8.39% last month
  • Did PTCT's Share Price Rise Over The Last Year?
    PTCT share price fell by -18.47% over the past 1 year

What Is PTC Therapeutics 52-Week High & Low?

PTC Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy PTC Therapeutics?

  • How Much Debt Does PTC Therapeutics Have?
    Total long term debt quarterly is $284.5M
  • How Much Cash Does PTC Therapeutics Have?
    Cash and short term investments quarterly total is $884.8M
  • What Is PTC Therapeutics’s Book Value Per Share?
    Book value per share is -11.66

Is PTC Therapeutics Cash Flow Positive?

  • What Is PTCT Cash Flow From Operations?
    Cash flow from operations (TTM) is -$58.2M
  • What Is PTC Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $642.8M
  • What Is PTC Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$262.7M

PTC Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    PTCT return on invested capital is -425.51%
  • What Is PTC Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -36.7%
  • What Is PTCT Return On Equity?
    ROE is a measure of profitability and is 0%

PTC Therapeutics Earnings Date & Stock Price

PTC Therapeutics Competitors

PTC Therapeutics Dividend Yield

Data Unavailable

PTC Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -9.09%
Revenue: -4.66% 28.26%

Analyst Recommendations

Buy Recommendations: 4
Hold Recommendations: 5
Sell Recommendations: 1
Price Target: 38.33
Upside from Last Price: 17.48%

Major Shareholders

  • How many PTCT shares are owned by institutional investors?
    137.7M PTCT shares are owned by institutional investors
  • How many PTCT shares are owned by insiders?
    1.3M PTCT shares are owned by insiders